BioSpace News Archive

Business

SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2017

Preliminary and unaudited revenue for fourth quarter 2017 is expected to be in the range of $34.2 million to $34.4 million.

January 8, 2018
·
5 min read
Drug Development

Flexion Therapeutics Announces Initial Data from Clinical Trial Evaluating Repeat Administration of ZILRETTA (Triamcinolone Acetonide Extended-Release Injectable Suspension)

Data show that 95% of patients achieved clinical benefit after a single administration of ZILRETTA.

January 8, 2018
·
6 min read
Drug Development

Mateon Announces New Preclinical Data Demonstrating Enhanced Tumor Immune Responses when CA4P is Given in Combination With Checkpoint Inhibitors

The new findings show that treatment with the combination of CA4P and an anti-CTLA-4 antibody nearly doubles the amount of tumor necrosis.

January 8, 2018
·
4 min read
Business

Actinium Pharmaceuticals Appoints Dr. Dale L. Ludwig, Ph.D. as CSO to Lead Efforts Focused on the Company’s AWE Technology Platform and Research Programs

Dr. Ludwig was a member of the Oncology Research Senior Leadership Team at Eli Lilly and Company.

January 8, 2018
·
9 min read
Pharm Country

Amicus Therapeutics Provides Full-Year 2018 Strategic Outlook and Financial Guidance

Amicus is focused on five key strategic priorities in 2018.

January 8, 2018
·
11 min read
Biotech Bay

Biotricity Expands its R&D Effort to Capitalize on Artificial Intelligence

Properly executed this could lead to an improvement in detection quality and patient outcomes while driving down costs and potentially providing another product opportunity for Biotricity.

January 8, 2018
·
5 min read
Selexis SA to Participate at Several Upcoming Industry Conferences

Selexis SA, announced today its planned participation at upcoming industry conferences for the first part of 2018.

January 8, 2018
·
3 min read
Pharm Country

Adaptimmune Announces Positive Safety Data From Pilot Studies With MAGE-A10 SPEAR T-cells and First Patient to Receive 1 Billion Target Cell Dose

To date, 8 patients have each received 100 million transduced MAGE‑A10 SPEAR T-cells in the first dose cohorts of both studies.

January 8, 2018
·
4 min read
Business

UroGen Pharma Appoints Former Kite Pharma Executive Christine Cassiano as Corporate Affairs Officer

Ms. Cassiano is a communications executive with wide experience in investor relations, corporate communications, media relations, brand strategy and public affairs.

January 8, 2018
·
5 min read
Biotech Bay

Agios Outlines Key 2018 Priorities Expanding Clinical and Research Programs to Drive Long Term Value

The presentation will outline how Agios’ clinical and research programs have the potential to provide meaningful benefit to a large number of patients.

January 8, 2018
·
10 min read